Filter posts

Driving Innovation in Breast Cancer: Startup Challenge

The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for …

State Legislation Needed For Substitution of Interchangeable Biologics

A great deal of the media coverage relating to California’s Senate Bill 598  neglects to …

Involving Patients in the Research Process

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, …

Propel Small Business Innovation through Tax Reform

As CEO of an emerging clinical-stage biotech company, I lose over $10 million each year. …

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and …

Amid Doping Scandals, Industry Must Remain Vigilant

As doping in sport makes its way back into the news of the day, we …

When is the Evidence “Enough” to Make a Health Care Decision?

At any given time, work is taking place in hundreds of laboratories throughout the country …

NORD Urges Congress: Don’t Cut Orphan Drug Tax Credit

This week, the National Organization of Rare Disorders (NORD) and more than 70 patient organizations …

The Michael J. Fox Foundation Launches $10 Million Edmond J. Safra Core Programs

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has committed up to $10 million …

Biodefense Preparedness Key for National Public Health

Over the last decade, our nation has responded to deliberate biological attacks – the mailing …